17
Views
2
CrossRef citations to date
0
Altmetric
TREATMENT OUTCOME PAPERS

Adolescents with Co-Occurring Substance Use and Mental Conditions in a Private Managed Care Health Plan: Prevalence, Patient Characteristics, and Treatment Initiation and Engagement

, MPH, , MPH, MSW & , DrPH, MSW
Pages 67-79 | Received 03 Apr 2006, Accepted 17 Aug 2006, Published online: 10 Jul 2009

REFERENCES

  • Bukstein OG, Glancy LJ, Kaminer Y. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry. 1992;31:1041–1045.
  • Grilo CM, Becker DF, Walker ML, Levy KN, Edell WS, McGlashan TH. Psychiatric comorbidity in adolescent inpatients with substance use disorders. J Am Acad Child Adolesc Psychiatry. 1995;34:1085–1091.
  • Kandel DB, Johnson JG, Bird HR, , et al. Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA Study. J Am Acad Child Adolesc Psychiatry. 1999;38:693–699.
  • Whitmore EA, Mikulich SK, Ehlers KM, Crowley TJ. One-year outcome of adolescent females referred for conduct disorder and substance abuse/dependence. Drug Alcohol Depend. 2000;59:131–141.
  • Riggs PD, Baker S, Mikulich SK, Young SE, Crowley TJ. Depression in substance-dependent delinquents. J Am Acad Child Adolesc Psychiatry. 1995;34:764–771.
  • Loeber R, Green SM, Lahey BB, Frick PJ, McBurnett K. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin Child Fam Psychol Rev. 2000;3:37–60.
  • White HR, Xie M, Thompson W, Loeber R, Stouthamer-Loeber M. Psychopathology as a predictor of adolescent drug use trajectories. Psychol Addict Behav. 2001;15:210–218.
  • Brown SA, Gleghorn A, Schuckit MA, Myers MG, Mott MA. Conduct disorder among adolescent alcohol and drug abusers. J Stud Alcohol. 1996;57:314–324.
  • Grella CE, Hser YI, Joshi V, Rounds-Bryant J. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis. 2001;189:384–392.
  • Kaminer Y. Addictive disorders in adolescents. Psychiatr Clin North Am. 1999;22:275–288.
  • Myers MG, Stewart DG, Brown SA. Progression from conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse. Am J Psychiatry. 1998;155:479–485.
  • Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol. 1988;49:219–224.
  • Randall J, Henggeler SW, Pickrel SG, Brondino MJ. Psychiatric comorbidity and the 16-month trajectory of substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry. 1999;38:1118–1124.
  • Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res. 1999;35 Suppl:S93–S100.
  • Babor TF, Dolinsky ZS, Meyer RE, Hesselbrock M, Hofmann M, Tennen H. Types of alcoholics: concurrent and predictive validity of some common classification schemes. Br J Addict. 1992;87:1415–1431.
  • Gonzalez G, Rosenheck RA. Outcomes and service use among homeless persons with serious mental illness and substance abuse. Psychiatr Serv. 2002;53:437–446.
  • Kaminer Y, Tarter RW, Bukstein OG, Kabene M. Comparison between treatment completers and noncompleters among dually diagnosed substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry. 1992;31:1046–1049.
  • Dobkin PL, Chabot L, Maliantovitch K, Craig W. Predictors of outcome in drug treatment of adolescent inpatients. Psychol Rep. 1998;83:175–786.
  • National Mental Health Association. What have states done to ensure health insurance parity? (on-line). 2006. Available at: http://www.nmha.org/state/parity/state_parity.cfm. Accessed Jun 30, 2006.
  • Institute of Medicine. Improving the Quality of Health Care for Mental and Substance-Use Conditions: Quality Chasm Series. Washington, DC: National Academies Press; 2005.
  • Peck MC. State health care reform: mental health parity for children in California. Psychiatr Serv. 2001;52:743–745, 768.
  • U.S. Department of Health and Human Services. Mental Health: A Report of the Surgeon General—Executive Summary. Rockville, MD: Center for Mental Health Services, Substance Abuse and Mental Health Services Administration; 1999.
  • Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occuring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996;66:17–31.
  • DeMilio L. Psychiatric syndromes in adolescent substance abusers. Am J Psychiatry. 1989;146:1212–1214.
  • Greenbaum PE, Prange ME, Friedman RM, Silver SE. Substance abuse prevalence and comordibity with other psychiatric disorders among adolescents with severe emotional disturbances. J Am Acad Child Adolesc Psychiatry. 1991;30:575–583.
  • Clark DB, Pollock N, Bukstein OG, Mezzich AC, Bromberger JT, Donovan JE. Gender and comorbid psychopathology in adolescents with alcohol dependence. J Am Acad Child Adolesc Psychiatry. 1997;36:1195–1203.
  • Hser Y-I, Grella CE, Hubbard RL, , et al. An evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry. 2001;58:689–695.
  • Sterling S, Weisner C. Chemical dependency and psychiatric services for adolescents in private managed care: implications for outcomes. Alcohol Clin Exp Res. 2005;25:801–809.
  • Fehon DC, Becker DF, Grilo CM, , et al. Diagnostic comorbidity in hospitalized adolescents with conduct disorder. Compr Psychiatry. 1997;38:141–145.
  • King RD, Gaines LS, Lambert EW, Summerfelt WT, Bickman L. The co-occurrence of psychiatric and substance use diagnoses in adolescents in different service systems: frequency, recognition, cost, and outcomes. J Behav Health Serv Res. 2000;27:417–430.
  • Kramer TL, Robbins JM, Phillips SD, Miller TL, Burns BJ. Detection and outcomes of substance use disorders in adolescents seeking mental health treatment. J Am Acad Child Adolesc Psychiatry. 2003;42:1318–1326.
  • Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry. 1987;44:505–513.
  • Whitmore EA, Mikulich SK, Thompson LL, Riggs PD, Aarons GA, Crowley TJ. Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender. Drug Alcohol Depend. 1997;47:87–97.
  • Rowe CL, Liddle HA, Greenbaum PE, Henderson CE. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. J Subst Abuse Treat. 2004;26:129–140.
  • Cornelius JR, Maisto SA, Martin CS, , et al. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav. 2004;29:1035–1038.
  • Horner BR, Scheibe KE. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Acad Child Adolesc Psychiatry. 1997;36:30–36.
  • Gilbert M, Fine S, Haley G. Factors associated with dropout from group psychotherapy with depressed adolescents. Can J Psychiatry. 1994;39:358–359.
  • Wise BK, Cuffe SP, Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat. 2001;21:161–165.
  • Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36:1–10.
  • Aday L, Andersen RM. A framework for the study of access to medical care. Health Serv Res. 1974;9:208–220.
  • Weisner C, Schmidt LA. Rethinking access to alcohol treatment. Recent Dev Alcohol. 2001;15:107–136.
  • Weisner C. Access to alcohol treatment in the 21st century. Old worries and new optimism. Overview. Recent Dev Alcohol. 2001;15:99–105.
  • Schmidt L, Weisner C. Public health perspectives on access and need for substance abuse treatment. In: Tucker JA, Donovan DM, Marlatt GA, eds. Changing Addictive Behavior: Bridging Clinical and Public Health Strategies. New York: Guildford Press;1999:67–96.
  • Booth BM, Staton M, Leukefeld C. Substance use health services research. Subst Use Misuse. 2001;36:673–685.
  • Grilo CM, Becker DF, Fehon DC, Edell WS, McGlashan TH. Conduct disorder, substance use disorders, and coexisting conduct and substance use disorders in adolescent inpatients. Am J Psychiatry. 1996;153:914–920.
  • Lewinsohn PM, Gotlib IH, Seeley JR. Adolescent psychopathology: IV. Specificity of psychosocial risk factors for depression and substance abuse in older adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34:1221–1229.
  • Blood L, Cornwall A. Pretreatment variables that predict completion of an adolescent substance abuse treatment program. J Nerv Ment Dis. 1994;182:14–19.
  • Brook JS, Richter L, Rubenstone E. Consequences of adolescent drug use on psychiatric disorders in early adulthood. Ann Med. 2000;32:401–407.
  • Clark DB. The natural history of adolescent alcohol use disorders. Addiction. 2004;99 Suppl 2:5–22.
  • Crowley TJ, Mikulich SK, Macdonald M, Young SE, Zerbe GO. Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcomes. Drug Alcohol Depend. 1998;49:225–237.
  • Substance Abuse and Mental Health Services Administration. Report to Congress on the Prevention and Treatment of Co-occurring Substance Abuse Disorders and Mental Disorders. Bethesda, MD: Department of Health and Human Services; 2002.
  • Edmunds M, Frank R, Hogan M, McCarty D, Robinson-Beale R, Weisner C, eds. Managing Managed Care: Quality Improvement in Behavioral Health. Washington, DC: National Academy Press; 1997.
  • Weisner C, McCarty D, Schmidt L. New directions in alcohol and drug treatment under managed care. Am J Manag Care. 1999;5:SP57–SP69.
  • Horgan CM, Merrick EL. Financing of substance abuse treatment services. Recent Dev Alcohol. 2001;15:229–252.
  • Weisner C, Conell C, Hunkeler E, , et al. Drinking patterns and problems of the ‘stably insured’: a study of the membership of a health maintenance organization. J Stud Alcohol. 2000;61:121–129.
  • Sterling S, Hinman A, Kohn CS, Weisner C. Pathways to Substance Abuse Treatment for Adolescents: Implications for Policy. Summary of provider Interviews. Report to Robert Wood Johnson Foundation. Oakland, CA: Division of Research, Kaiser Permanente Northern California; 2002.
  • Alaja R, Seppa K, Sillanaukee P, , et al. Physical and mental co-morbidity of substance use disorders in psychiatric consultations. European Consultation-Liaison Workgroup. Alcohol Clin Exp Res. 1998;22:1820–1824.
  • Sterling S, Kohn CS, Lu Y, Weisner C. Pathways to substance abuse treatment for adolescents in an HMO. J Psychoactive Drugs. 2004;36:439–453.
  • Saluja G, Iachan R, Scheidt PC, Overpeck MD, Sun W, Giedd JN. Prevalence of and risk factors for depressive symptoms among young adolescents. Arch Pediatr Adolesc Med. 2004;158:760–765.
  • Lipschitz DS, Rasmusson AM, Anyan W, Cromwell P, Southwick SM. Clinical and functional correlates of posttraumatic stress disorder in urban adolescent girls at a primary care clinic. J Am Acad Child Adolesc Psychiatry. 2000;39:1104–1111.
  • Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison to matched controls. Arch Intern Med. 2003;163:2511–2517.
  • Mertens JM, Weisner C, Ray GT, Fireman B, Walsh K. Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs. Alcohol Clin Exp Res. 2005;29:989–998.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.